Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1979-10-05-1979-12-03
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
comparable to guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1979
Report date:
1979

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
not specified
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
1,1'-[(6-phenyl-1,3,5-triazine-2,4-diyl)diimino]bisanthraquinone
EC Number:
223-912-2
EC Name:
1,1'-[(6-phenyl-1,3,5-triazine-2,4-diyl)diimino]bisanthraquinone
Cas Number:
4118-16-5
Molecular formula:
C37H21N5O4
IUPAC Name:
1,1'-[(6-phenyl-1,3,5-triazine-2,4-diyl)diimino]di(9,10-anthraquinone)

Test animals

Species:
hamster, Chinese
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: 4-6 weeks old
- Weight at study initiation: 27-37g
- Housing: Individually in Macrolon cages
- Diet: NAFAG, Gossau SG, ad libitum
- Drinking water: ad libitum

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2°C
- Humidity (%): 55 +/- 10 %
- Photoperiod: 10 hours light

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
polyethylene glycol
Details on oral exposure:
DOSAGE PREPARATION: The test item was suspended to achieve the corresponding dosage level. Before treatment the suspension was homogeneously dispersed with an Ultra-Turrax and during treatment it was kept stable with a magnetic stirrer.
Volume: 10 and 20 mL/kg body weight
Doses:
3000, 4000, 5000, 6000 mg/kg bw
No. of animals per sex per dose:
5 male
5 female
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations: Bodyweight: Immediately prior to dosing and after 7 and 14 days.
Clinical observations: Daily

Results and discussion

Preliminary study:
none
Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 6 000 mg/kg bw
Based on:
test mat.
Mortality:
no mortality
Clinical signs:
other: Total recovery within 7-8 days Sedation: Slight effects, recovery after 2 days (3000 mg/kg) Slight effects, recovery after 5 days (all other dose groups) Dyspnoe: Slight effects, recovery after 7 days (3000 mg/kg) Slight effects, recovery after 6 days
Gross pathology:
No substance related gross organ changes were seen.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met